Tuberculosis in the United States National Tuberculosis Surveillance System Highlights from 2010

All materials on our website are shared by users. If you have any questions about copyright issues, please report us to resolve them. We are always happy to assist you.
 186 views
of 27

Please download to get full document.

View again

Description
Tuberculosis in the United States National Tuberculosis Surveillance System Highlights from 2010. National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. Division of Tuberculosis Elimination. Reported TB Cases United States, 1982–2010*. No. of Cases. Year.
Share
Transcript
Tuberculosis in the United StatesNational Tuberculosis Surveillance SystemHighlights from 2010 National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Division of Tuberculosis Elimination Reported TB Cases United States, 1982–2010* No. of Cases Year *Updated as of July 21, 2011 TB MorbidityUnited States, 2005–2010 *Cases per 100,000. Updated as of July 21, 2011 TB Case Rates,* United States, 2010 D.C. <3.6 (2010 national average) >3.6 *Cases per 100,000. TB Case Rates* by Age Group United States, 1993–2010 Cases per 100,000 Age Group (years) * Updated as of July 21, 2011 Reported TB Cases by Age Group, United States, 2010 TB Case Rates by Age Group and Sex, United States, 2010 Cases per 100,000 TB Case Rates by Race/Ethnicity* United States, 2003–2010** Cases per 100,000 *All races are non-Hispanic. **Updated as of July 21, 2011. TB Case Rates by Age Group and Race/Ethnicity* United States, 2010 Cases per 100,000 *All races are non-Hispanic. Persons reporting two or more races accounted for less than 1% of all cases. Reported TB Cases by Race/Ethnicity* States, 2010United States, 2010 *All races are non-Hispanic. Persons reporting two or more races accounted for less than 1% of all cases. Number of TB Cases in States, 2010U.S.-born vs. Foreign-born Persons United States, 1993–2010* No. of Cases *Updated as of July 21, 2011 Trends in TB Cases in Foreign-born Persons States, 2010United States, 1990 – 2010* No. of Cases Percentage *Updated as of July 21, 2011 Reported TB Cases by Origin and Race/Ethnicity,* United States, 2010 Foreign-born** U.S.-born *All races are non-Hispanic. Persons reporting two or more races accounted for less than 1% of all cases. ** American Indian or Alaska Native and Native Hawaiian or Other Pacific Islander accounted for less than 1% of foreign-born cases and are not shown. Percentage of TB Cases Among States, 2010Foreign-born Persons, United States* 2000 2010 DC DC >50% 25%–49% *Updated as of July 21, 2011 <25% TB Case Rates in U.S.-born vs. Foreign-born Persons, United States, 1993 – 2010* Cases per 100,000 *Updated as of July 21, 2011 TB Case Rates in U.S.-born vs. Foreign-born Persons, United States*, 1993 – 2010** Cases per 100,000 *Includes the same data as slide 15, but rates presented on a logarithmic scale. **Updated as of July 21, 2011 Countries of Birth of Foreign-born Persons Reported with TB, United States, 2010 Percent of Foreign-born with TB by Time of Residence in U.S. Prior to Diagnosis, 2010 *Foreign-born TB patients for whom information on length of residence in the U.S. prior to diagnosis is unknown or missing Primary Anti-TB Drug Resistance Prior to Diagnosis, 2010United States, 1993 – 2010* % Resistant *Updated as of July 21, 2011 Note: Based on initial isolates from persons with no prior history of TB. Multidrug resistant TB (MDR TB) is defined as resistance to at least isoniazid and rifampin Primary MDR TB Prior to Diagnosis, 2010United States, 1993 – 2010* No. of Cases Percentage *Updated as of July 21, 2011 Note: Based on initial isolates from persons with no prior history of TB. MDR TB defined as resistance to at least isoniazid and rifampin. Primary Isoniazid Resistance in Prior to Diagnosis, 2010U.S.-born vs. Foreign-born PersonsUnited States, 1993 – 2010* % Resistant *Updated as of July 21, 2011 Note: Based on initial isolates from persons with no prior history of TB. Primary MDR TB in Prior to Diagnosis, 2010U.S.-born vs. Foreign-born PersonsUnited States, 1993 – 2010* % Resistant *Updated as of July 21, 2011 Note: Based on initial isolates from persons with no prior history of TB. MDR TB defined as resistance to at least isoniazid and rifampin. XDR TB Case Count Defined on Initial DST Prior to Diagnosis, 2010*by Year, 1993 – 2010** Case Count Year of Diagnosis * Drug susceptibility test ** Updated as of July 21, 2011 Note: Extensively drug-resistant TB (XDR TB) is defined as resistance to isoniazid and rifampin, plus resistance to any fluoroquinolone and at least one of three injectable second-line anti-TB drugs Reporting of HIV Test Results Prior to Diagnosis, 2010in Persons with TB by Age GroupUnited States, 1993 – 2010* % with Test Results *Updated as of July 21, 2011 Note: Includes TB patients with positive, negative, or indeterminate HIV test results. HIV test results not reported from California after 2004. HIV test results not reported from Rhode Island for years 1993-1997. HIV test results not reported from Vermont after 2007. Estimated HIV Coinfection in Persons Prior to Diagnosis, 2010Reported with TB, United States, 1993 – 2010* % Coinfection *Updated as of July 21, 2011 Note: Minimum estimates based on reported HIV-positive status among all TB cases in the age group Mode of Treatment Administration Prior to Diagnosis, 2010in Persons Reported with TBUnited States, 1993 – 2008* Percentage** *Updated as of July 21, 2011. Data available through 2008 only. **Percentage of total cases in persons alive at diagnosis, with an initial regimen of one or more drugs prescribed, and excluding cases with unknown mode of treatment administration. Directly observed therapy (DOT); Self-administered therapy (SA) Completion of TB Therapy Prior to Diagnosis, 2010United States, 1993 – 2008* Percentage * Updated as of July 21, 2011. Data available through 2008 only. Note: Includes persons alive at diagnosis, with initial drug regimen of one or more drugs prescribed, who did not die during therapy. Excludes persons with initial isolate rifampin resistant, or patient with meningeal disease, or pediatric patient (aged <15) with miliary disease or positive blood culture.
Related Search
We Need Your Support
Thank you for visiting our website and your interest in our free products and services. We are nonprofit website to share and download documents. To the running of this website, we need your help to support us.

Thanks to everyone for your continued support.

No, Thanks